1,850
Participants
Start Date
June 30, 2005
Primary Completion Date
September 30, 2017
Study Completion Date
December 31, 2022
Collaborators (3)
Bristol-Myers Squibb
INDUSTRY
GlaxoSmithKline
INDUSTRY
Merck Serono International SA
INDUSTRY
Roche Pharma AG
INDUSTRY
Schering-Plough
INDUSTRY
ANRS, Emerging Infectious Diseases
OTHER_GOV